# TCR² Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tcr-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.tcr2.com
- Total disclosed funding: $170M
- Latest round: Series B (Mar 21, 2018)
- Investors on record: 15

## About

Founded in 2015 and based in Massachusetts, US, TCR2 Therapeutics Inc. is a company that engages in developing therapies and signaling T cells for cancer treatment. The company develops The TRuC™ Platform, a novel T cell therapy platform, which uses the complete T cell receptor (TCR) complex without the need for human leukocyte antigen (HLA) matching.

## Funding rounds

- Series B, Mar 21, 2018, $125M — Alexandria Venture Investments, MPM BioImpact, ArrowMark Partners, Leerink Partners, F2 Ventures, Hillhouse Investment, Redmile Group, Cathay Fortune Corporation, 6 Dimensions Capital, Haitong International Securities Group, Syno Capital, Mirae Asset Venture Investment, Lucion Venture Capital Group, Sirona Capital, Curative Ventures
- Series A, Dec 7, 2016, $45M — MPM BioImpact, F2 Ventures

## Investors

- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A, Series B
- F2 Ventures (https://capitalatlas.ai/funds/f2-ventures) — Series A, Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- ArrowMark Partners — Series B
- Leerink Partners — Series B
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series B
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series B
- Cathay Fortune Corporation — Series B
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series B
- Haitong International Securities Group — Series B
- Syno Capital (https://capitalatlas.ai/funds/syno-capital) — Series B
- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series B
- Lucion Venture Capital Group — Series B
- Sirona Capital (https://capitalatlas.ai/funds/sirona-capital) — Series B
- Curative Ventures (https://capitalatlas.ai/funds/curative-ventures) — Series B